G2 Investment Partners Initiates a New Position in Xometry

G2 Investment Partners opened a new position in Xometry of 221,679 shares worth $13.2M, representing 3.1% of the fund’s AUM. Xometry reported TTM revenue of $686.6M and Q4 revenue growth of 30% YoY to $192M but remains unprofitable (TTM net loss $61.8M; Q4 GAAP loss $8.6M). Shares are down 34.8% YTD through Mar 17 but up 50.9% over the last year; G2 managed $420.7M AUM across 71 positions at year-end.

Analysis

Xometry’s business is a classic two-sided marketplace where marginal growth in supplier and buyer density compounds through reduced lead times and higher conversion — but that same dynamic can dilute per-order economics if onboarding prioritized volume over pricing discipline. Expect the next material margin lever to be “take rate expansion” (higher fees per transaction) and automation of quoting/fulfillment; if management can push take rate +100–200bps while holding supplier utilization steady, EBIT conversion could move from theoretical to visible within 12–24 months.

A less-obvious headwind is working-capital and quality-control leakage as the network scales. Faster matching increases receivables and disputes; absent stronger supplier SLAs and insurance-backed settlements, growth can create nonlinear increases in SG&A and warranty-like costs. Conversely, a focus on higher-margin verticals (aerospace, medical) or captive tooling services could meaningfully re-rate multiples if they convert 10–15% of GMV to recurring, higher-LTV revenues over 2–3 years.

Investor flows amplify idiosyncratic moves here: modest buys/sells by concentrated funds materially shift price and implied volatility, creating fertile ground for asymmetric option plays. The clearest near-term catalysts are (1) evidence of sustainable take-rate uplift, (2) a path to GAAP profitability via expense control, and (3) supplier SLA metrics that substantively reduce post-sale churn; absent those, the stock is vulnerable to multiple compression in a macro slowdown.

Key Decisions for Investors

• XMTR — Buy a low-cost asymmetric call spread: long 12-month ATM call, sell 12-month call 35–45% OTM sized for 0.5–1.0% portfolio risk. Entry trigger: share price down 15–25% from current levels or immediately on next-quarter take-rate beat. R/R: potential 2–4x if take rate and GMV mix improve; loss limited to premium paid.
• XMTR — Small equity starter (1–2% portfolio) with disciplined exits: target +40–60% in 9–18 months, hard stop -30%. Rationale: capture network effects while limiting downside from GAAP profitability risk; trim on rallies into news-driven volatility spikes.
• Pair trade — Long XMTR / Short CLS (equal notional) for 6–12 months to express marketplace outperformance vs traditional EMS exposure. Thesis: XMTR should compound faster if it converts higher-margin vertical work; unwind if the spread tightens >20% or if both report synchronized GM weakness.
• Event-driven options — Buy strangles 7–10 days into earnings windows only if implied vol < 1.2x historical realized vol; otherwise sell premium (covered calls) after strong earnings. This captures amplified liquidity-driven moves while sizing so single-event losses remain <0.5% portfolio.